99 related articles for article (PubMed ID: 30876538)
1. Detection of KRAS G12D point mutation level by anchor-like DNA electrochemical biosensor.
Zeng N; Xiang J
Talanta; 2019 Jun; 198():111-117. PubMed ID: 30876538
[TBL] [Abstract][Full Text] [Related]
2. An Ultrasensitive Electrochemical DNA Biosensor Based on Carboxylated Multi-walled Carbon Nanotube/Molybdenum Disulfide Composites for KRAS Gene Detection.
Wang X; Yang M; Liu Q; Yang S; Geng X; Yang Y; Fa H; Wang Y; Hou C
Anal Sci; 2019 Apr; 35(4):441-448. PubMed ID: 30606912
[TBL] [Abstract][Full Text] [Related]
3. Optimisation of an Electrochemical DNA Sensor for Measuring KRAS G12D and G13D Point Mutations in Different Tumour Types.
Attoye B; Baker MJ; Thomson F; Pou C; Corrigan DK
Biosensors (Basel); 2021 Feb; 11(2):. PubMed ID: 33562505
[TBL] [Abstract][Full Text] [Related]
4. A Pterin-FAM-TAMRA Tri-color Fluorescence Biosensor to Detect the Level of KRAS Point Mutation.
Zeng N; Guo Y; Xiang J
Anal Sci; 2020 Dec; 36(12):1529-1533. PubMed ID: 32830162
[TBL] [Abstract][Full Text] [Related]
5. Piezoelectric Plate Sensor (PEPS) for Analysis of Specific KRAS Point Mutations at Low Copy Number in Urine Without DNA Isolation or Amplification.
Kirimli CE; Shih WH; Shih WY
Methods Mol Biol; 2017; 1572():327-348. PubMed ID: 28299698
[TBL] [Abstract][Full Text] [Related]
6. Detection of
Olmedillas-López S; Lévano-Linares DC; Alexandre CLA; Vega-Clemente L; Sánchez EL; Villagrasa A; Ruíz-Tovar J; García-Arranz M; García-Olmo D
World J Gastroenterol; 2017 Oct; 23(39):7087-7097. PubMed ID: 29093617
[TBL] [Abstract][Full Text] [Related]
7. An electrochemiluminescence biosensor for Kras mutations based on locked nucleic acid functionalized DNA walkers and hyperbranched rolling circle amplification.
Zhang Y; Wang L; Luo F; Qiu B; Guo L; Weng Z; Lin Z; Chen G
Chem Commun (Camb); 2017 Mar; 53(20):2910-2913. PubMed ID: 28154878
[TBL] [Abstract][Full Text] [Related]
8. Designing a fluorescence padlock probe-based biosensor and colorimetric assay for the detection of G12D
Mahmoudian F; Akbariqomi M; Heidari R; Ghahremani MH; Roshan N; Adabi M; Absalan M; Karimi F; Bahrami S; Fathi S; Tavoosidana G
Biomark Med; 2021 Dec; 15(18):1741-1754. PubMed ID: 34784779
[No Abstract] [Full Text] [Related]
9. Comparison of the prevalence of KRAS-LCS6 polymorphism (rs61764370) within different tumour types (colorectal, breast, non-small cell lung cancer and brain tumours). A study of the Czech population.
Uvirova M; Simova J; Kubova B; Dvorackova N; Tomaskova H; Sedivcova M; Dite P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):466-71. PubMed ID: 26077004
[TBL] [Abstract][Full Text] [Related]
10. Immobilization free electrochemical biosensor for folate receptor in cancer cells based on terminal protection.
Ni J; Wang Q; Yang W; Zhao M; Zhang Y; Guo L; Qiu B; Lin Z; Yang HH
Biosens Bioelectron; 2016 Dec; 86():496-501. PubMed ID: 27442079
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccine elicits an efficient antitumor response by targeting the mutant Kras in a transgenic mouse lung cancer model.
Weng TY; Yen MC; Huang CT; Hung JJ; Chen YL; Chen WC; Wang CY; Chang JY; Lai MD
Gene Ther; 2014 Oct; 21(10):888-96. PubMed ID: 25077772
[TBL] [Abstract][Full Text] [Related]
12. Synergistic enhanced rolling circle amplification based on mutS and radical polymerization for single-point mutation DNA detection.
Lee S; You J; Baek I; Park H; Jang K; Park C; Na S
Biosens Bioelectron; 2022 Aug; 210():114295. PubMed ID: 35477153
[TBL] [Abstract][Full Text] [Related]
13. Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue.
Ako S; Nouso K; Kinugasa H; Dohi C; Matushita H; Mizukawa S; Muro S; Akimoto Y; Uchida D; Tomoda T; Matsumoto K; Horiguchi S; Tsutsumi K; Kato H; Okada H
Pancreatology; 2017; 17(2):285-290. PubMed ID: 28139399
[TBL] [Abstract][Full Text] [Related]
14. Amplification-free in situ KRAS point mutation detection at 60 copies per mL in urine in a background of 1000-fold wild type.
Kirimli CE; Shih WH; Shih WY
Analyst; 2016 Feb; 141(4):1421-33. PubMed ID: 26783561
[TBL] [Abstract][Full Text] [Related]
15. Detection of KRAS mutations using double-stranded toehold-exchange probes.
Wu Z; Ma T; Coll JL; Liu F; Zhang H; Ma Y; Wang Z; Jin Q; Mao H; Zhao J
Biosens Bioelectron; 2016 Jun; 80():175-181. PubMed ID: 26829579
[TBL] [Abstract][Full Text] [Related]
16. Detection of KRAS Mutations in Plasma DNA Using a fully Automated Rapid Detection System in Colorectal Cancer Patients.
Hosoya K; Matsusaka S; Kashiwada T; Suzuki K; Ureshino N; Sato A; Miki Y; Kitera K; Hirai M; Hatake K; Kimura S; Sueoka-Aragane N
Pathol Oncol Res; 2017 Oct; 23(4):737-744. PubMed ID: 28058585
[TBL] [Abstract][Full Text] [Related]
17. KRAS mutation testing on all non-malignant diagnosis of pancreatic endoscopic ultrasound-guided fine-needle aspiration biopsies improves diagnostic accuracy.
Trisolini E; Armellini E; Paganotti A; Veggiani C; Bozzola C; Frattini M; Pizio C; Mancuso G; Andorno S; Boldorini R
Pathology; 2017 Jun; 49(4):379-386. PubMed ID: 28450086
[TBL] [Abstract][Full Text] [Related]
18. In situ, amplification-free double-stranded mutation detection at 60 copies/ml with thousand-fold wild type in urine.
Kirimli C; Lin S; Su YH; Shih WH; Shih WY
Biosens Bioelectron; 2018 Nov; 119():221-229. PubMed ID: 30142581
[TBL] [Abstract][Full Text] [Related]
19. Label-free and high-sensitive detection of Kirsten rat sarcoma viral oncogene homolog and epidermal growth factor receptor mutation using Kelvin probe force microscopy.
Jang K; Choi J; Park C; Na S
Biosens Bioelectron; 2017 Jan; 87():222-228. PubMed ID: 27566395
[TBL] [Abstract][Full Text] [Related]
20. Novel Methodology for Rapid Detection of KRAS Mutation Using PNA-LNA Mediated Loop-Mediated Isothermal Amplification.
Itonaga M; Matsuzaki I; Warigaya K; Tamura T; Shimizu Y; Fujimoto M; Kojima F; Ichinose M; Murata S
PLoS One; 2016; 11(3):e0151654. PubMed ID: 26999437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
